![](/img/cover-not-exists.png)
Hypoxia-Selective Targeting by the Bioreductive Prodrug AQ4N in Patients with Solid Tumors: Results of a Phase I Study
Albertella, M. R., Loadman, P. M., Jones, P. H., Phillips, R. M., Rampling, R., Burnet, N., Alcock, C., Anthoney, A., Vjaters, E., Dunk, C. R., Harris, P. A., Wong, A., Lalani, A. S., Twelves, C. J.Volume:
14
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-07-4020
Date:
February, 2008
File:
PDF, 694 KB
english, 2008